Anticoagulant Reversal

Slides:



Advertisements
Similar presentations
J. Bormanis/ cg edits  When did it start ?  Dental history  Spontanous bruising  Bleeding at surgery  Bleeding into joints  Menstrual bleeding.
Advertisements

Reversal of TSOACs 1 st Qatar Conference on Safe Anticoagulation Management (QCSAM): New Advances and Trends 28 February 2015 Scott Kaatz, DO, MSc, FACP,
What a Bloody Mess! A/Professor Kent Robinson Senior Staff Specialist, Liverpool & Campbelltown Hospitals.
Chapter 19 Agents Affecting Blood Clotting. Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved Blood.
ANAESTHESIA AND ANTICOAGULANTS
Cristy M. Thomas FNP-BC University of Nevada School of Medicine University Medical Center, Las Vegas NV Nevada’s Only Level 1 Adult Trauma, Level 2 Pediatric.
Vascular Pharmacology
MTP Octaplex rFVIIa Calgary. Massive Transfusion Protocol.
Anticoagulation in the Acute Care Population Aimee Ring PT, DPT, GCS.
Principles of anticoagulant tratment
Dalia Elfawy., MD Lecturer of Anesthesia and ICU Ain Shams University 2014 RAPID REVERSAL OF ANTICOAGULATION IN TRAUMA PATIENTS.
Senior clinician Request: a o 4 units RBC o 2 units FFP Consider: a o 1 adult therapeutic dose platelets o tranexamic acid in trauma patients Include:
Journal Club – September Coagulation – Brief Review.
ANTICOAGULANT BY :DR ISRAA OMAR.
Principles of Hematology in Relation to Dental Management Dr. Saleh Al-Bazie, BDS, OMFS (USA), D.Sc.D, Consultant, OMFS, KSU, SHMC.
NURS 1950 Pharmacology I 1.  Objective 1: identify general reasons anticoagulants are given 2.
Care of the Anti-coagulated Trauma Patient Julie Mayglothling, MD, FACEP Emergencies in Medicine March 8 th, 2012.
Anticoagulant, Antiplatelet, and Thrombolytic Drugs
COAGULATION & ANTICOAGULATION Dr Rakesh Jain. A set of reactions in which blood is transformed from a liquid to a gel Coagulation follows intrinsic and.
Anticoagulants 1. Parenteral Anticoagulants e.g. heparin
FERNE/EMRA How do we treat ICH patients with an elevated INR Andy Jagoda, MD, FACEP Professor and Vice Chair Department of Emergency Medicine Mount Sinai.
Role of Factor Concentrates in Perioperative Coagulopathies Dr Neville Gibbs Department of Anaesthesia Sir Charles Gairdner Hospital.
 Background  Cost  Benefit  Complication.
ASPIRIN ↓ Cox inhibition ↓ (PROSTACYCLIN) PGI 2 & TXA 2 (THROMBOXANE) LOW DOSE ASPIRIN.
Fibrinolytics, anticoagulants and antiplatelets
Investigation of Haemostasis MS. c. program Lab-9.
Anticoagulants and reversal
Anticoagulation Reversal May 11, Objectives Develop an approach for treating patients with iatrogenic coagulopathy Understand recent changes in.
Agents Affecting Blood Clotting
Coagulation Modifier Agents Lilley Pharmacology Text: Chapter 26 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed. Professor of Nursing Original.
Chapter 19 Agents affecting Blood Clotting. Blood Clotting p461 Clotting is necessary to prevent fatal loss of blood from a minor injury Thromboemboli.
Dr. Ryan Clark, DO Grandview Medical Center, Dayton, OH NOVEL ORAL ANTICOAGULANTS.
Patient Blood Management Guidelines: Module 6 Neonatal and Paediatrics Roles Senior clinician Coordinate team and allocate roles Determine volume and type.
Systemic anticoagulation during ECMO is intended to control thrombin generation and limit the risk for thrombotic and hemorrhagic complications.
BLOOD COMPONENTS AND BLOOD DERIVATIVES
Timeline of Anticoagulation Options
ANTIPLATELETS AND ANTICOAGULANTS
Prothrombin Complex Concentrate- Octaplex
Robert A. Harrington, MD Professor of Medicine
Anesthes. 2013;118(6): doi: /ALN.0b013e318289bcba Figure Legend:
AUB:Iatrogent Coagulopathy
Rapid Reversal of Warfarin Therapy in Patients with Intracranial / Intraspinal Bleeding Mount Auburn Hospital Blood Bank, Emergency Department, Critical.
Warfarin Toxicity Treatment & Management
General Principles of Hemostasis Kristine Krafts, M.D.
Anticoagulants in the Treatment of Venous Thromboembolism
Anticoagulant therapy
Anticoagulation in chronic liver disease
Ortho Warfarin Dosing Protocol
Med Chem Tutoring for Anticoagulants, Antiplatelets, and Thrombolytics
Use of NOACs is contraindicated for AF patients with mechanical prosthetic valves or moderate- severe mitral stenosis (usually of rheumatic origin). Although.
In the name of God. Management trauma in elderly DR. NIKSOLAT GERIATRICIAN ASSISTANT PROFESSOR, IRAN UNIVERSITY OF MEDICAL SCIENCE.
and anti-thrombotic pharmocology Tom Williams
Coagulation Cascade of the Newborn
Anticoagulation Prepared by Cherie Gan.
Matthew P. Lillyblad, PharmD, BCPS-AQ Cardiology
Reversal of Direct Oral Anticoagulants (DOAC)
“Reversing Direct Oral Anticoagulants”
Reversal by the specific antidote, idarucizumab, of elevated dabigatran exposure in a patient with rectal perforation and paralytic ileus  C. Thorborg,
Direct Oral Anticoagulants
General Principles of Hemostasis Kristine Krafts, M.D.
Oral Anticoagulant Reversal Agents
Periprocedural Management of Patients on Anticoagulation
Nat. Rev. Cardiol. doi: /nrcardio
A. Kisilevsky, A.W. Gelb, M. Bustillo, A.M. Flexman 
Journal club govaresh Dr ali gavidel Dr sadr azar.
New oral anticoagulants and regional anaesthesia
Drug Summary Info Document Request / monitor Goal of therapy Action
Effects of vitamin K antagonists (VKA), such as warfarin, low-molecular-weight heparin (LMWH), and dabigatran, on the coagulation pathway. Effects of vitamin.
Use Fixed low dose Prothrombin Complex Concentrate (Octaplex)
Presentation transcript:

Anticoagulant Reversal Prepared by Shane Barclay MD

Objectives Define the role for anticoagulant reversal. Review of bleeding management – general principles. Coagulation assays. Reversal treatment options.

Role for anticoagulant reversal Major life threatening bleeding for patients on any type of anticoagulation can be problematic. In addition to standard bleeding management, one should be aware of specific treatment options for specific anticoagulants.

Bleeding Management – acute case Discontinue anticoagulants. Control active bleeding (pressure). Appropriate IV fluids, oxygen, CV support. Packed red blood if available. If available, FFP for patients on ASA, Clopidogrel, or other platelet inhibitors. Other specific measures as discussed next.

Remember this?! Tissue trauma, vascular injury

Where anticoagulants work Heparin/Low Molecular Weight Heparin: - Inhibits Xa, Ixa, XIIa and Thrombin - measured by PTT Warfarin: - Inhibits VII, IX, X - measured by INR Direct Oral Anticoagulants (DOAC) - Direct Thrombin Inhibitors (Dabigatran) - Direct Factor Xa inhibitors (“Xabans”) (Rivaroxaban, Apixaban…)

Where anticoagulants work

Where DOACs work

Coagulation Assays PTT – measures the intrinsic pathway - of some use with Unfractionated Heparin. INR and PT – measures extrinsic pathway. - useful for Warfarin Thrombin Time (TT) - can be used if patient on Dabigatran. DOACs generally have little or no effect on PT/INR or PTT

Anticoagulation Reversal Options Protamine sulfate Vitamin K Tranexamic Acid Activated Charcoal Packed Red Blood cells Platelets Prothrombin Complex Concentrates (PCCs) Specific DOAC reversal agents

Anticoagulation Reversal Options DRUG REVERSAL AGENT Heparin Protamine Sulfate 1mg per 100 units heparin at 5 mg/min. Max 50 mg Check PPT at 15 min, then 2-8 hrs.

Anticoagulation Reversal Options DRUG REVERSAL AGENT LMWH Protamine Sulfate 1mg per mg LMWH if last injection < 8 hrs. 0.5 mg per mg LMWH if last injection > 8 hrs. 0.5 mg per mg if bleeding persists after 4 hrs of first dose. Max infusion 5 mg/min Single dose not to exceed 50 mg

Anticoagulation Reversal Options DRUG REVERSAL AGENT Warfarin Vitamin K 2 – 10 mg IV Prothrombin Complex (Beriplex) INR 2-3.9 25 units/kg (max 2500u) INR 4-5.9 35 units/kg (max 3500u) INR > 6 50 units/kg (max 5000u) If PCC not available Fresh Frozen Plasma 10 – 20 ml/kg plus Vitamin K 5 – 10 mg IV

Anticoagulation Reversal Options DRUG REVERSAL AGENT Dabigatran Idarucizumab (Praxbind) 25 mg q 15 min x 2 doses. Activated Charcoal 100 g PO if ingestion < 2 hrs. Tranexamic acid 25 mg/kg IV Desmopressin 0.3 mcg/kg SQ or IV

Anticoagulation Reversal Options DRUG REVERSAL AGENT Apixaban/ Activated Charcoal 100 g PO Rivaroxaban if ingestion < 6 hrs. PCC 50 units/kg max 5000 units. Tranexamic acid 25 mg/kg IV Desmopressin 0.3 mg/kg SQ/IV FFP not recommended.

Summary Patients presenting with acute life threatening bleeding and who are on anticoagulants need special management and often very specific treatment to reverse their bleeding. You need to be aware of the various types of anticoagulants and the treatment options available in your center.